BostonGene
Waltham, United States· Est.
BostonGene develops AI-powered molecular and immune profiling solutions to personalize cancer therapy and improve patient outcomes.
Private Company
Total funding raised: $400M
About
BostonGene develops AI-powered molecular and immune profiling solutions to personalize cancer therapy and improve patient outcomes.
OncologyAI / Machine LearningDiagnostics
Funding History
4Total raised:$400M
Series B$150M
Series B$150M
Series A$50M
Series A$50M